- Home
- MKSI vs ROIV Comparison
MKSI vs ROIV Comparison
Compare MKSI & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MKSI | ROIV |
|---|---|---|
| Founded | 1961 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4B | 20.7B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MKSI | ROIV |
|---|---|---|
| Price | $222.19 | $26.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | ★ $255.62 | $27.56 |
| AVG Volume (30 Days) | 1.1M | ★ 4.4M |
| Earning Date | 05-06-2026 | 02-06-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | ★ 55.52 | N/A |
| EPS | ★ 4.37 | N/A |
| Revenue | ★ $3,931,000,000.00 | $29,053,000.00 |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | $10.58 | $594.84 |
| P/E Ratio | $51.57 | ★ N/A |
| Revenue Growth | ★ 9.62 | N/A |
| 52 Week Low | $54.84 | $8.73 |
| 52 Week High | $269.91 | $30.33 |
Technical Indicators
Market Signals| Indicator | MKSI | ROIV |
|---|---|---|
| Relative Strength Index (RSI) | 45.38 | 42.52 |
| Support Level | $209.20 | $20.46 |
| Resistance Level | $246.35 | $27.94 |
| Average True Range (ATR) | 11.55 | 0.88 |
| MACD | -0.09 | -0.38 |
| Stochastic Oscillator | 31.29 | 1.04 |
Price Performance
Historical ComparisonAbout MKSI MKS Instruments Inc.
MKS Inc delivers foundational technology solutions for leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. The company provides instruments, components, subsystems, systems, process control solutions, and specialty chemicals technology that improve process performance and optimize productivity. Its solutions address challenges of miniaturization and complexity in device manufacturing, enabling increased power, speed, and feature enhancement. MKS Inc operates through three divisions: Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Materials Solutions Division (MSD). The company operates in the United States, which generates maximum revenue, as well as China and other countries.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.